Recombinant SARS-COV-2 Spike S1 (N501Y) Protein

SARS-CoV-2 Spike S1 (N501Y) Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.

$The purity of SARS-COV-2 Spike S1 (N501Y) Protein is greater than 95% as determined by SEC-HPLC.\r\n$

The purity of SARS-COV-2 Spike S1 (N501Y) Protein is greater than 95% as determined by SEC-HPLC.\r\n

$Immobilized SARS-CoV-2 Spike S1 (N501Y) Protein, His Tag at 0.5ug\/ml (100ul\/Well). Dose-response curve for ACE2, Fc tag with the EC50 of 80.3ng\/ml determined by ELISA.$

Immobilized SARS-CoV-2 Spike S1 (N501Y) Protein, His Tag at 0.5ug\/ml (100ul\/Well). Dose-response curve for ACE2, Fc tag with the EC50 of 80.3ng\/ml determined by ELISA.

Applications

WB
ELISA
HPLC

Reactivity

SARS-CoV-2

Overview
Catalog #	bs-46012P
Product Name	Recombinant SARS-COV-2 Spike S1 (N501Y) Protein
Applications	WB, ELISA, HPLC
Reactivity	SARS-CoV-2
Specifications
Conjugation	Unconjugated
Source	SARS-COV-2 Spike S1 (N501Y) Protein is expressed with a His-tag at the C-terminal.
Storage Buffer	Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization.
Storage Condition	The product should be stored at -70°C or -20°C.
Target
Gene ID	YP_009724390.1
Background	A new variant of SARS-CoV-2 is spreading in the UK and is rapidly becoming a global threat. It is characterized by multiple mutations in the spike protein. Among them, N501Y is of major concern because it involves one of the six key amino acid residues determining a tight interaction of the SARS-CoV-2 receptor-binding domain (RBD) with its cellular receptor angiotensin-converting enzyme 2 (ACE2).